LLY · Eli Lilly and Company
1153.00
USDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
US$1.09T
PE
46.80
EV/EBITDA
31.6
DIV Yield
0.6%
Payout Ratio
26%
MQV Rating
2Strong
As at 18/09/2026 04:10:00 PM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- HALO 200
- HALO 50
- HALO 500
- HALO All
- HALO Capital Efficiency
- HALO Dividend Growth
- Hammer Bullish (Realtime)
Key Fundamentals
EPS 3 yr Growth
232.10%
EBITDA Margin
48.60%
Operating Cashflow
$16,813m
Free Cash Flow Return
30.20%
ROIC
37.10%
Interest Coverage
N/A
Quick Ratio
1.20
Performance
52 weeks range
Low 712.05 - 1292.65
Trade Value (12mth)
US$816,500,972.00
1 week
3.34%
1 month
-7.35%
YTD
6.72%
1 year
53.32%
All time high
1292.65
Additional Data
Shares Outstanding (Fully Diluted)
894m
HALO Sector
Healthcare
Next Company Report Date
10-Feb-27
Next Ex Dividend Date
14-Aug-26
Next Dividend Pay Date
10-Sep-26
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Strong
Garp
Strong
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Neutral
Growth
Earnings
Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Neutral
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
06 August 26EDG | |
05 August 26EDG | |
05 August 26EDG | |
24 June 26EDG | |
21 May 26EDG |
Key Stakeholders
| Name | Title |
| Lilly Endowment, Inc. | Non-Profit Organization |
| David A. Ricks | Individual |
| Employees Provident Fund | Pension Fund |
| OrbiMed Advisors Private Equity | Subsidiary |
| Daniel M. Skovronsky | Individual |
